CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy

Bicky Thapa, Paolo F. Caimi, Kirit M. Ardeshna, Melhem Solh, Carmelo Carlo-Stella, Brad S. Kahl, Mehdi Hamadani

Research output: Contribution to journalArticlepeer-review

40 Scopus citations
Original languageEnglish
Pages (from-to)3850-3852
Number of pages3
JournalBlood Advances
Issue number16
StatePublished - Aug 25 2020

Cite this